Oncology Clinical Pathways Spotlight
This week in health care trends, our oncology clinical pathways spotlight includes Uber for healthcare, the Cadillac tax, and a practical guide to clinical pathways.
The articles below are from our dedicated Oncology Clinical Pathways e-magazine. We’re constantly adding valuable content to this updateable magazine, so make sure to check out this e-magazine (and others) frequently for new intelligence. You can follow us on Flipboard or Twitter, or just watch for the links to this and our other magazines in our regular weekly BioBlog emails. (Don’t get our emails yet? Subscribe here!)
In the age of mobile apps and the “sharing economy,” a variety of healthcare startups are competing to create a healthcare version of Uber that brings doctors and nurses right into the patient’s home via technology.
A recent survey by the National Business Group on Health found that an increasing number of large employers “will require employees to get prior authorization before buying specialty drugs under the employer’s health plan — 53 percent vs. 29 percent a year ago.”
This practical guide answers the question, “What exactly is a clinical pathway?” as well as addressing the various things that pathways programs can include and the difference between pathways and clinical guidelines.
This AJMC article takes a tour through the origins of precision medicine in oncology, why precision oncology is critical right now, and how payers are responding. It also argues that “payers can now benefit from proactively taking strategic steps to integrate precision oncology into coverage and alternative payment models,” and offers specific suggestions for how to do so.